Other health problems that could harm an applicant’s chances include sickle cell disease, knee injuries, poor dental hygiene, deafness, and anxiety or depression. Food allergies or being an ...

Editas on Thursday kicked off a cost-cutting transition initiative after its hunt for a development sponsor for its sickle cell disease therapy renizgamglogene autogedtemcel turned up empty. As part ...

It feels like the Splinter Cell remake has been on its way for a while now, which isn't helped by the fact it's been over two years since we heard anything official about the game. From what we've ...

Editas Medicine said Thursday afternoon it will lay off 65% of its staff — around 180 employees — as it shelves its lead gene-editing program for sickle cell disease and shifts focus.

The company instead chose to focus resources on testing the therapy that would become reni-cel in sickle cell and beta thalassemia, two blood disorders that were already the target of rivals CRISPR ...

Funmi Dasaolu receives funding from The National Institute for Health and Care Research. Stephen Hibbs receives funding from the Wellcome Trust. In December 2023, 34-year-old Dave Onawelo told ...

Tim Walz and our state Legislature for their leadership in creating a pathway to give Minnesotans access to transformative therapies for sickle cell disease. People struggling with chronic ...

Renowned content creator Bon Sevic has passed away after a lifelong battle with sickle cell disease The Kibra-based digital creator inspired many through his heartfelt and engaging interviews on ...

The dual Wiz and ZBTB7A degrader entered into a first Phase 1/2 sickle cell disease trial in July, 1 month ahead of a similar compound from Novartis. “It’s a super exciting molecule and a ...

One year on from the landmark U.S. approval of two powerfully effective gene therapies for sickle cell disease, the treatments have been barely used, a sluggish start that reflects the myriad ...